US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US5011472A
(en)
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
ES2325045T3
(en)
|
1996-10-14 |
2009-08-24 |
Bayer Healthcare Ag |
NEW DERIVATIVES OF PIRAZOL HETEROCICLILMETIL SUBSTITUTED AND ITS USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES.
|
DE19642255A1
(en)
|
1996-10-14 |
1998-04-16 |
Bayer Ag |
Use of 1-benzyl-3- (substituted-hetaryl) fused pyrazole derivatives
|
DE19649460A1
(en)
|
1996-11-26 |
1998-05-28 |
Bayer Ag |
New substituted pyrazole derivatives
|
ES2251200T3
(en)
|
1998-07-08 |
2006-04-16 |
Sanofi-Aventis Deutschland Gmbh |
SULPHONYLAMINOCARBOXYLIC ACID N-ARILAMIDS REPLACED WITH SULFUR, ITS USE AND PHARMACEUTICAL PREPARATIONS THAT UNDERSTAND THEM.
|
DE19834047A1
(en)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituted pyrazole derivatives
|
DE19834044A1
(en)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
New substituted pyrazole derivatives
|
DE19943635A1
(en)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Novel aminodicarboxylic acid derivatives with pharmaceutical properties
|
DE19943634A1
(en)
|
1999-09-13 |
2001-04-12 |
Bayer Ag |
Novel dicarboxylic acid derivatives with pharmaceutical properties
|
DE19943636A1
(en)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Novel dicarboxylic acid derivatives with pharmaceutical properties
|
DE19943639A1
(en)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Dicarboxylic acid derivatives with novel pharmaceutical properties
|
DE10054278A1
(en)
|
2000-11-02 |
2002-05-08 |
Bayer Ag |
Use of soluble guanylate cyclase stimulators for the treatment of osteoporosis
|
DE10057754A1
(en)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
|
DE10057751A1
(en)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
|
CA2429308C
(en)
|
2000-11-22 |
2010-09-21 |
Bayer Aktiengesellschaft |
Novel lactam-substituted pyrazolopyridine derivatives
|
AR031176A1
(en)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE
|
DE10109861A1
(en)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Novel side chain halogenated aminodicarboxylic acid derivatives
|
DE10109859A1
(en)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Novel aminodicarboxylic acid derivatives
|
DE10109858A1
(en)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Novel halogen-substituted aminodicarboxylic acid derivatives
|
DE10110749A1
(en)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituted aminodicarboxylic acid derivatives
|
DE10110750A1
(en)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Novel aminodicarboxylic acid derivatives with pharmaceutical properties
|
DE10122894A1
(en)
|
2001-05-11 |
2002-11-14 |
Bayer Ag |
New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
|
DE10132416A1
(en)
|
2001-07-04 |
2003-01-16 |
Bayer Ag |
New morpholine-bridged pyrazolopyridine derivatives
|
US20030016677A1
(en)
|
2001-07-17 |
2003-01-23 |
Karl Mauritz |
Fabric bus architeture
|
DE10220570A1
(en)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamate-substituted pyrazolopyridines
|
DE10222550A1
(en)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
New 1-benzyl-3-(2-pyrimidinyl)-pyrazolo-(3,4-b)-pyridine derivatives are soluble guanylate cyclase stimulants, useful e.g. for treating cardiovascular or thromboembolic diseases or sexual dysfunction
|
DE10232572A1
(en)
|
2002-07-18 |
2004-02-05 |
Bayer Ag |
New 2,5-disubstituted pyrimidine derivatives
|
DE102005050377A1
(en)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Ag |
Heterocyclic compounds and their use
|
DE102005050376A1
(en)
|
2005-10-21 |
2007-05-31 |
Bayer Healthcare Ag |
Dicarboxylic acid derivatives and their use
|
DE102005050375A1
(en)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Ag |
Tetrazole derivatives and their use
|
DE102005050497A1
(en)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Ag |
Difluorophenol derivatives and their use
|
DE102005050498A1
(en)
|
2005-10-21 |
2007-06-06 |
Bayer Healthcare Aktiengesellschaft |
Cyclopropylacetic acid derivatives and their use
|
DE102006020327A1
(en)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclic substituted, fused pyrazole derivatives and their use
|
DE102006043443A1
(en)
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Novel aza-bicyclic compounds and their use
|
DE102006054757A1
(en)
|
2006-11-21 |
2008-05-29 |
Bayer Healthcare Ag |
Novel aza-bicyclic compounds and their use
|
DE102007015034A1
(en)
|
2007-03-29 |
2008-10-02 |
Bayer Healthcare Ag |
Lactam-substituted dicarboxylic acids and their use
|
DE102007015035A1
(en)
|
2007-03-29 |
2008-10-02 |
Bayer Healthcare Ag |
Substituted dibenzoic acid derivatives and their use
|
KR20100059952A
(en)
|
2007-09-06 |
2010-06-04 |
머크 샤프 앤드 돔 코포레이션 |
Soluble guanylate cyclase activators
|
WO2009068652A1
(en)
|
2007-11-30 |
2009-06-04 |
Smithkline Beecham Corporation |
2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines as soluble guanylate cyclase activators
|
PE20091258A1
(en)
|
2007-12-03 |
2009-09-12 |
Smithkline Beecham Corp |
PYRIDINE DERIVATIVES AS SOLUBLE GUANILATE CYCLASE ACTIVATORS
|
US8946439B2
(en)
*
|
2008-02-29 |
2015-02-03 |
Evotec Ag |
Amide compounds, compositions and uses thereof
|
EP2264017A4
(en)
|
2008-04-04 |
2011-07-27 |
Takeda Pharmaceutical |
Heterocyclic derivative and use thereof
|
DE102008018675A1
(en)
|
2008-04-14 |
2009-10-15 |
Bayer Schering Pharma Aktiengesellschaft |
Oxo-heterocyclic substituted carboxylic acid derivatives and their use
|
WO2010015652A2
(en)
|
2008-08-07 |
2010-02-11 |
Smithkline Beecham Corporation |
Thiazole compounds as activators of soluble guanylate cyclase
|
WO2010015653A1
(en)
|
2008-08-07 |
2010-02-11 |
Smithkline Beecham Corporation |
Pyrimidine derivatives as activators of soluble guanylate cyclase
|
AU2009322836B2
(en)
|
2008-11-25 |
2013-04-04 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
DE102009004245A1
(en)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Novel fused, heteroatom-bridged pyrazole and imidazole derivatives and their use
|
MX2011008952A
(en)
|
2009-02-26 |
2011-09-27 |
Merck Sharp & Dohme |
Soluble guanylate cyclase activators.
|
DE102009012314A1
(en)
|
2009-03-09 |
2010-09-16 |
Bayer Schering Pharma Aktiengesellschaft |
Oxo-heterocyclic substituted alkylcarboxylic acids and their use
|
DE102010001064A1
(en)
|
2009-03-18 |
2010-09-23 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
|
DE102009046115A1
(en)
|
2009-10-28 |
2011-09-08 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted 3-phenylpropanoic acids and their use
|
SI2539326T1
(en)
|
2010-02-27 |
2017-08-31 |
Bayer Intellectual Property Gmbh |
Bisaryl-bonded aryltriazolones and use thereof
|
WO2011115804A1
(en)
|
2010-03-17 |
2011-09-22 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
WO2011119518A1
(en)
|
2010-03-25 |
2011-09-29 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
DE102010020553A1
(en)
|
2010-05-14 |
2011-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted 8-alkoxy-2-aminotetralin derivatives and their use
|
DE102010021637A1
(en)
|
2010-05-26 |
2011-12-01 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted 5-fluoro-1H-pyrazolopyridines and their use
|
WO2011149921A1
(en)
|
2010-05-27 |
2011-12-01 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
UY33476A
(en)
|
2010-06-30 |
2012-02-29 |
Ironwood Pharmaceuticals Inc |
SGC STIMULATORS
|
EP2590987B1
(en)
|
2010-07-09 |
2016-03-09 |
Bayer Intellectual Property GmbH |
Condensed 4-aminopyrimidines and their use as stimulators of soluble guanylate cyclase
|
MX2013000198A
(en)
|
2010-07-09 |
2013-01-28 |
Bayer Ip Gmbh |
Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases.
|
DE102010040233A1
(en)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclic aza heterocycles and their use
|
WO2012058132A1
(en)
|
2010-10-28 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
DE102010043380A1
(en)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Benzyl-substituted carbamates and their use
|
DE102010043379A1
(en)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
|
RU2582679C2
(en)
|
2010-11-09 |
2016-04-27 |
Айронвуд Фармасьютикалз, Инк. |
sGC STIMULATORS
|
AU2011340721A1
(en)
|
2010-12-07 |
2013-06-20 |
Bayer Intellectual Property Gmbh |
Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
|
EP2683710B1
(en)
|
2011-03-10 |
2017-07-19 |
Boehringer Ingelheim International GmbH |
Soluble guanylate cyclase activators
|
DE102011007272A1
(en)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Branched 3-phenylpropionic acid derivatives and their use
|
WO2012143510A1
(en)
|
2011-04-21 |
2012-10-26 |
Bayer Intellectual Property Gmbh |
Fluoroalkyl-substituted pyrazolopyridines and use thereof
|
CN103649093B
(en)
|
2011-05-06 |
2017-07-07 |
拜耳知识产权有限责任公司 |
Substituted imidazopyridine and Imidazopyridazine and application thereof
|
DE102011075398A1
(en)
|
2011-05-06 |
2012-11-08 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazopyridazines and their use
|
CA2836202A1
(en)
|
2011-05-30 |
2012-12-06 |
Astellas Pharma Inc. |
Imidazopyridine compounds
|
RU2014103960A
(en)
|
2011-07-06 |
2015-08-20 |
Байер Интеллектуэль Проперти Гмбх |
Heteroaryl substituted pyrazolopyridines and their use as soluble guanylate cyclase stimulants
|
EP2766360B1
(en)
|
2011-08-12 |
2017-07-12 |
Boehringer Ingelheim International GmbH |
Soluble guanylate cyclase activators
|
KR20140068112A
(en)
|
2011-09-02 |
2014-06-05 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
Substituted annellated pyrimidine and the use thereof
|
CN106117194A
(en)
|
2011-12-27 |
2016-11-16 |
铁木医药有限公司 |
Can be used as 2 benzyls of SGC stimulant, 3 (pyrimidine 2 base) substituted pyrazoles
|
DE102012200349A1
(en)
|
2012-01-11 |
2013-07-11 |
Bayer Intellectual Property Gmbh |
Substituted fused pyrimidines and triazines and their use
|
DE102012200352A1
(en)
|
2012-01-11 |
2013-07-11 |
Bayer Intellectual Property Gmbh |
Substituted, fused imidazoles and pyrazoles and their use
|
DE102012200360A1
(en)
|
2012-01-11 |
2013-07-11 |
Bayer Intellectual Property Gmbh |
Substituted triazines and their use
|
JP6140738B2
(en)
|
2012-03-06 |
2017-05-31 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
Substituted azabicycles and uses thereof
|
RU2640416C2
(en)
|
2012-04-16 |
2018-01-09 |
Тоа Эйо Лтд. |
Bicyclic compound
|
UA112897C2
(en)
|
2012-05-09 |
2016-11-10 |
Байєр Фарма Акцієнгезелльшафт |
BICYCLIC SUBSTITUTED URATILES AND THEIR APPLICATIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES
|
DE102012208530A1
(en)
|
2012-05-22 |
2013-11-28 |
Bayer Pharma AG |
Substituted piperidinoacetamides and their use
|
US9387203B2
(en)
|
2012-07-20 |
2016-07-12 |
Bayer Pharma Aktiengesellschaft |
Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
|
MY172994A
(en)
|
2012-07-20 |
2019-12-18 |
Bayer Pharma AG |
Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
|
AP2015008231A0
(en)
|
2012-09-07 |
2015-01-31 |
Boehringer Ingelheim Int |
Alkoxy pyrazoles as soluble guanylate cyclase activators
|
US9309235B2
(en)
|
2012-09-18 |
2016-04-12 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
US9487508B2
(en)
|
2012-09-19 |
2016-11-08 |
Ironwood Pharmaceuticals, Inc. |
SGC stimulators
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
CN104822680B
(en)
|
2012-11-30 |
2016-10-12 |
安斯泰来制药株式会社 |
Imidazopyridine
|
BR112015019571A2
(en)
|
2013-02-21 |
2017-07-18 |
Adverio Pharma Gmbh |
methyl {4,6-diamino-2- [1- (2-fluorobenzyl) -1h-pyrazolo [3,4-b] pyridin-3-yl] pyrimidin-5-yl} methylcarbamate forms
|
AU2014222739A1
(en)
|
2013-03-01 |
2015-09-03 |
Bayer Pharma Aktiengesellschaft |
Trifluormethyl-substituted ring-fused pyrimidines and use thereof
|
WO2014131741A1
(en)
|
2013-03-01 |
2014-09-04 |
Bayer Pharma Aktiengesellschaft |
Benzyl-substituted pyrazolopyridines and use thereof
|
EP3004094B1
(en)
|
2013-06-04 |
2017-03-01 |
Bayer Pharma Aktiengesellschaft |
3-aryl-substituted imidazo[1,2-a]pyridines and the use thereof
|
UY35652A
(en)
|
2013-07-10 |
2015-01-30 |
Bayer Pharma AG |
BENCIL-1H-PIRAZOLO [3,4-B] PIRIDINES AND ITS USE
|
US9422285B2
(en)
|
2013-08-08 |
2016-08-23 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereof
|
CN105899510A
(en)
|
2013-08-08 |
2016-08-24 |
拜耳制药股份公司 |
Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof
|
CA2921395C
(en)
|
2013-08-23 |
2022-04-26 |
Afferent Pharmaceuticals Inc. |
Diaminopyrimidine p2x3 and p2x 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough
|
EP3041836A1
(en)
|
2013-09-05 |
2016-07-13 |
GlaxoSmithKline Intellectual Property Development Limited |
Novel soluble guanylate cyclase activators and their use
|
US9714213B2
(en)
|
2013-10-15 |
2017-07-25 |
Toa Eiyo Ltd. |
4-aminomethylbenzoic acid derivative
|
US9783552B2
(en)
|
2013-12-11 |
2017-10-10 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
CA2933250A1
(en)
|
2013-12-11 |
2015-06-18 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
US9611278B2
(en)
|
2013-12-11 |
2017-04-04 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase activators
|
US9796733B2
(en)
|
2014-06-04 |
2017-10-24 |
Merck Sharp & Dohme Corp. |
Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators
|
EP3161745A4
(en)
|
2014-06-30 |
2017-12-06 |
Shaaban, Ahmed, Farouk |
Improved system and method for billing
|
TW201625601A
(en)
|
2014-07-02 |
2016-07-16 |
諾華公司 |
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
|
TW201625584A
(en)
|
2014-07-02 |
2016-07-16 |
諾華公司 |
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
|
TW201625586A
(en)
|
2014-07-02 |
2016-07-16 |
諾華公司 |
Cyclohexen-1-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
|
HUE049231T2
(en)
|
2014-07-22 |
2020-09-28 |
Boehringer Ingelheim Int |
Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
|
CN107223125B
(en)
|
2014-09-17 |
2019-09-27 |
赛科理音医疗有限公司 |
SGC stimulant
|
CN107406422B
(en)
|
2014-09-17 |
2022-02-01 |
赛科理音医疗有限公司 |
Pyrazole derivatives as sGC stimulators
|
EP3194386A2
(en)
|
2014-09-17 |
2017-07-26 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
MX2017003621A
(en)
|
2014-09-19 |
2017-07-14 |
Glaxosmithkline Ip Dev Ltd |
Novel soluble guanylate cyclase activators and their use.
|
PL3215498T3
(en)
|
2014-11-03 |
2019-02-28 |
Bayer Pharma Aktiengesellschaft |
Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
|
TW201625635A
(en)
|
2014-11-21 |
2016-07-16 |
默沙東藥廠 |
Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
|
SI3230281T1
(en)
*
|
2014-12-09 |
2021-08-31 |
Bayer Aktiengesellschaft |
1,3-thiazol-2-yl substituted benzamides
|
WO2017070084A1
(en)
*
|
2015-10-19 |
2017-04-27 |
Cardioxyl Pharmaceuticals, Inc. |
N-hydroxylsulfonamide derivatives as nitroxyl donors
|